pd168393 has been researched along with Cancer of Lung in 3 studies
PD 168393 : A member of the class of quinazolines carrying bromoanilino and acrylamido substituents at positions 4 and 6 respectively.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carmi, C | 1 |
Cavazzoni, A | 1 |
Vezzosi, S | 1 |
Bordi, F | 1 |
Vacondio, F | 1 |
Silva, C | 1 |
Rivara, S | 1 |
Lodola, A | 1 |
Alfieri, RR | 1 |
La Monica, S | 1 |
Galetti, M | 1 |
Ardizzoni, A | 1 |
Petronini, PG | 1 |
Mor, M | 1 |
Sos, ML | 2 |
Rode, HB | 1 |
Heynck, S | 1 |
Peifer, M | 1 |
Fischer, F | 1 |
Klüter, S | 1 |
Pawar, VG | 1 |
Reuter, C | 1 |
Heuckmann, JM | 1 |
Weiss, J | 1 |
Ruddigkeit, L | 1 |
Rabiller, M | 1 |
Koker, M | 1 |
Simard, JR | 1 |
Getlik, M | 1 |
Yuza, Y | 1 |
Chen, TH | 1 |
Greulich, H | 1 |
Thomas, RK | 2 |
Rauh, D | 1 |
Zander, T | 1 |
Staratschek-Jox, A | 1 |
Claasen, J | 1 |
Wolf, J | 1 |
3 other studies available for pd168393 and Cancer of Lung
Article | Year |
---|---|
Novel irreversible epidermal growth factor receptor inhibitors by chemical modulation of the cysteine-trap portion.
Topics: Aniline Compounds; Antineoplastic Agents; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Li | 2010 |
Chemogenomic profiling provides insights into the limited activity of irreversible EGFR Inhibitors in tumor cells expressing the T790M EGFR resistance mutation.
Topics: Afatinib; Amino Acid Substitution; Animals; Apoptosis; Blotting, Western; Carcinoma, Non-Small-Cell | 2010 |
Expression of signaling mediators downstream of EGF-receptor predict sensitivity to small molecule inhibitors directed against the EGF-receptor pathway.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Chromones; Drug Resistance, Neoplasm; Drug Screeni | 2008 |